October 5, 2018 by Chain Drug Review
National Community Pharmacists Association Foundation, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association Foundation has announced its planned activities during the NCPA 2018 Annual Convention in Boston, Mass. on Oct. 6-9. The Foundation’s booth in the NCPA exhibit hall will offer attendees the opportunity to learn about Foundation programs: Dispose My Meds, a national medication disposal program; disaster relief grants, which help
April 25, 2018 by Chain Drug Review
independent pharmacy, McKesson, NCPA, pharmacy ownership
Pharmacy
ALEXANDRIA, Va. – Ask pharmacist Hashim Zaibak how he came to own 11 pharmacies (all under the Hayat Pharmacy umbrella) in Milwaukee, and he’ll tell you about a workshop he attended several years ago, conducted by the National Community Pharmacists Association. “I had wanted to own my own store since pharmacy school,” Zaibak said, “But my training was in pharmacy, not business,
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 9, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, independent pharmacy owners, Medicare Part D, National Community Pharmacists Association, NCPA, S. 413 / H.R. 1038
CDR Blog
Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at
January 17, 2018 by Chain Drug Review
Centers for Medicare & Medicaid Services, DIR fees at the point of sale, Medicare Part D, Medicare Part D for 2019, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, Steve Anderson
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association have submitted comments to the Centers for Medicare & Medicaid Services (CMS) as it mulls Medicare Part D prescription drug program changes for the 2019 contract year. NACDS said Wednesday that in its comments to CMS the association expressed support for and provided added input
January 15, 2018 by Chain Drug Review
B. Douglas Hoey, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, CMS-4182-P Medicare Program, community pharmacies, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA, PBM business model, pharmacy benefit managers
2018, Issue 01-15-2018, Issues, Opinion
WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an
January 10, 2018 by B. Douglas Hoey and Chain Drug Review
B. Douglas Hoey, Community Care of North Carolina, community pharmacists, community pharmacy, CPESN–USA, DIR fees, IDNs, independent pharmacies, integrated delivery networks, National Community Pharmacists Association, NCPA, pharmacy benefit manager business model, pharmacy DIR legislation, prescription drug abuse
Opinion
Community pharmacy owners occupy a critical position in the pharmacy marketplace and, even more importantly, as health care providers in communities across the country. Most stakeholders in the profession understand the vital marketplace check and balance that independent businesses provide. If only two or three megachain drug stores existed, negotiations with payers would look very
December 13, 2017 by Chain Drug Review
B. Douglas Hoey, DIR fees, Examining the Drug Supply Chain, Mark Merritt, National Community Pharmacists Association, NCPA, PBM industry, Pharmaceutical Care Management Association, pharmacy benefit manager, prescription drug costs, U.S. House of Representatives Energy & Commerce Committee, video
Videos
At a health subcommittee hearing of the U.S. House of Representatives Energy & Commerce Committee, B. Douglas Hoey, CEO of the National Community Pharmacists Association (NCPA), called for legislative and regulatory action on pharmacy benefit manager (PBM) business practices to help rein in prescription drug costs. The hearing, titled “Examining the Drug Supply Chain”
November 6, 2017 by Jeffrey Woldt and Chain Drug Review
2017 NCPA Digest, B. Douglas Hoey, Community Pharmacy Enhanced Services Network, CPESN, independent drug stores, independent pharmacies, Jeffrey Woldt, National Community Pharmacists Association, NCPA
2017, Issue 11-06-2017, Issues, Opinion
More often than not, independent drug stores are overshadowed by the big retail chains. While it’s understandable why individual pharmacists who own one or two locations do not receive the same level of attention as the top pharmacy operators, the largest of which each have thousands of stores across the United States, in the aggregate
October 26, 2017 by Chain Drug Review
Centers for Medicare & Medicaid Services, Medicaid pharmacy reimbursement, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, Washington State Health Care Authority, Washington State Pharmacy Association, WSPA
Featured Articles, Leading Headlines, Pharmacy, Retail News
OLYMPIA, Wash. — The National Association of Chain Drug Stores, National Community Pharmacists Association and Washington State Pharmacy Association (WSPA) are challenging changes to Medicaid pharmacy reimbursement in Washington state. NACDS said Thursday that it teamed with NCPA and WSPA in filing a legal brief last week for a case involving the changes, which the
October 3, 2017 by Chain Drug Review
Department of Defense, James Mattis, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, National Defense Authorization Act for Fiscal Year 2018, NCPA, Tricare, TRICARE pilot, TRICARE Prescription Drug Acquisition Cost Parity Pilot
Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association have called on lawmakers to extend the TRICARE Prescription Drug Acquisition Cost Parity Pilot Program. NACDS and NCPA have sent a letter to House of Representatives and Senate Armed Services Committee leaders urging them to support a one-year extension
September 5, 2017 by Chain Drug Review
B. Douglas Hoey, Kevin Brady, National Community Pharmacists Association, NCPA, Orrin Hatch, tax reform
Business, Retail News
ALEXANDRIA, Va. — With tax reform now topping the congressional and Trump administration agendas, the National Community Pharmacists Association is speaking up on behalf of independent pharmacies. NCPA said Tuesday that it has sent a letter to Sen. Orrin Hatch (R., Utah), chairman of the Senate Finance Committee, and Rep. Kevin Brady (R., Texas), chairman
June 23, 2017 by Chain Drug Review
Act 900, Arkansas Pharmacists Association, B. Douglas Hoey, generic drug reimbursement, Mark Merritt, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, prescription drug pricing
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — The National Community Pharmacists Association and the Arkansas Pharmacists Association (APA) have filed an amici curiae brief in federal court against a challenge by the Pharmaceutical Care Management Association (PCMA). NCPA said the brief, filed in the U.S. Court of Appeals for the Eighth Circuit, supports Arkansas in a lawsuit initiated by
May 22, 2017 by Chain Drug Review
Centers for Medicare & Medicaid Services, H.R. 1038, H.R. 1316, H.R. 1939, H.R. 592, independent community pharmacies, Medicare, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — The National Community Pharmacists Association urged leaders in the House of Representatives to enact a slate of bills that would foster access to pharmacy services in Medicare. NCPA said Monday that it submitted comments for a House Ways and Means Health Subcommittee hearing on Medicare and offered suggestions to enhance the program